These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 28942696)

  • 1. GnRH antagonist does not prevent premature luteinization and ovulation in stimulated cycles with gonadotropins for IVF: two case reports.
    Inaudi P; Barra V; Vellucci FL; Regini C; Luisi S
    Gynecol Endocrinol; 2018 Mar; 34(3):189-191. PubMed ID: 28942696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Premature luteinization during gonadotropin-releasing hormone antagonist cycles and its relationship with in vitro fertilization outcome.
    Bosch E; Valencia I; Escudero E; Crespo J; Simón C; Remohí J; Pellicer A
    Fertil Steril; 2003 Dec; 80(6):1444-9. PubMed ID: 14667881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of GnRH antagonist fixed protocol and GnRH agonists long protocol in infertile patients with normal ovarian reserve function in their first in vitro fertilization-embryo transfer cycle].
    Yang S; Chen XN; Qiao J; Liu P; Li R; Chen GA; Ma CH
    Zhonghua Fu Chan Ke Za Zhi; 2012 Apr; 47(4):245-9. PubMed ID: 22781108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternate day and daily administration of GnRH antagonist may prevent premature luteinization to a similar extent during FSH treatment.
    Messinis IE; Loutradis D; Domali E; Kotsovassilis CP; Papastergiopoulou L; Kallitsaris A; Drakakis P; Dafopoulos K; Milingos S
    Hum Reprod; 2005 Nov; 20(11):3192-7. PubMed ID: 16037104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cetrorelix lowers premature luteinization rate in gonadotropin ovulation induction-intrauterine insemination cycles: a randomized-controlled clinical trial.
    Steward RG; Gill I; Williams DB; Witz CA; Griffith J; Haddad GF
    Fertil Steril; 2011 Jan; 95(1):434-6. PubMed ID: 20810107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mild ovarian stimulation strategy in women with poor ovarian reserve undergoing IVF: a multicenter randomized non-inferiority trial.
    Youssef MA; van Wely M; Al-Inany H; Madani T; Jahangiri N; Khodabakhshi S; Alhalabi M; Akhondi M; Ansaripour S; Tokhmechy R; Zarandi L; Rizk A; El-Mohamedy M; Shaeer E; Khattab M; Mochtar MH; van der Veen F
    Hum Reprod; 2017 Jan; 32(1):112-118. PubMed ID: 27836979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Live birth rates after modified natural cycle compared with high-dose FSH stimulation using GnRH antagonists in poor responders.
    Lainas TG; Sfontouris IA; Venetis CA; Lainas GT; Zorzovilis IZ; Tarlatzis BC; Kolibianakis EM
    Hum Reprod; 2015 Oct; 30(10):2321-30. PubMed ID: 26307091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Letrozole and gonadotropins versus luteal estradiol and gonadotropin-releasing hormone antagonist protocol in women with a prior low response to ovarian stimulation.
    Elassar A; Engmann L; Nulsen J; Benadiva C
    Fertil Steril; 2011 Jun; 95(7):2330-4. PubMed ID: 21514582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Differing response to GnRH antagonists in cycles of ovarian hyperstimulation plus intrauterine insemination].
    Barros-Delgadillo JC; Trejo-Castañeda H; E-Ormsby C; Gaviño-Gaviño F
    Ginecol Obstet Mex; 2010 Jan; 78(1):15-28. PubMed ID: 20931799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GnRH-agonist ovulation trigger in patients undergoing controlled ovarian hyperstimulation for IVF with ultrashort flare GnRH-agonist combined with multidose GnRH-antagonist protocol.
    Orvieto R; Nahum R; Zohav E; Liberty G; Anteby EY; Meltcer S
    Gynecol Endocrinol; 2013 Jan; 29(1):51-3. PubMed ID: 22857268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diminished ovarian reserve is the predominant risk factor for gonadotropin-releasing hormone antagonist failure resulting in breakthrough luteinizing hormone surges in in vitro fertilization cycles.
    Reichman DE; Zakarin L; Chao K; Meyer L; Davis OK; Rosenwaks Z
    Fertil Steril; 2014 Jul; 102(1):99-102. PubMed ID: 24882557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does premature luteinization or early surge of LH impair cycle outcome? Report of two successful outcomes.
    Sönmezer M; Pelin Cil A; Atabekoğlu C; Ozkavukçu S; Ozmen B
    J Assist Reprod Genet; 2009 Mar; 26(2-3):159-63. PubMed ID: 19224360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Administration of a gonadotropin-releasing hormone antagonist during the 3 days before the initiation of the in vitro fertilization/intracytoplasmic sperm injection treatment cycle: impact on ovarian stimulation. A pilot study.
    Blockeel C; Riva A; De Vos M; Haentjens P; Devroey P
    Fertil Steril; 2011 Apr; 95(5):1714-9.e1-2. PubMed ID: 21300334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extended high dose letrozole regimen versus short low dose letrozole regimen as an adjuvant to gonadotropin releasing hormone antagonist protocol in poor responders undergoing IVF-ET.
    Fouda UM; Sayed AM
    Gynecol Endocrinol; 2011 Dec; 27(12):1018-22. PubMed ID: 21714697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of gonadotropin type on progesterone elevation during ovarian stimulation in GnRH antagonist cycles.
    Lawrenz B; Beligotti F; Engelmann N; Gates D; Fatemi HM
    Hum Reprod; 2016 Nov; 31(11):2554-2560. PubMed ID: 27619773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initiation of ovarian stimulation independent of the menstrual cycle: a case-control study.
    Buendgen NK; Schultze-Mosgau A; Cordes T; Diedrich K; Griesinger G
    Arch Gynecol Obstet; 2013 Oct; 288(4):901-4. PubMed ID: 23545834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is earlier administration of human chorionic gonadotropin (hCG) associated with the probability of pregnancy in cycles stimulated with recombinant follicle-stimulating hormone and gonadotropin-releasing hormone (GnRH) antagonists? A prospective randomized trial.
    Kyrou D; Kolibianakis EM; Fatemi HM; Tarlatzis BC; Tournaye H; Devroey P
    Fertil Steril; 2011 Nov; 96(5):1112-5. PubMed ID: 21924414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mild/minimal stimulation for in vitro fertilization: an old idea that needs to be revisited.
    Zarek SM; Muasher SJ
    Fertil Steril; 2011 Jun; 95(8):2449-55. PubMed ID: 21550037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basal serum progesterone and history of elevated progesterone on the day of hCG administration are significant predictors of late follicular progesterone elevation in GnRH antagonist IVF cycles.
    Venetis CA; Kolibianakis EM; Bosdou JK; Lainas GT; Sfontouris IA; Tarlatzis BC; Lainas TG
    Hum Reprod; 2016 Aug; 31(8):1859-65. PubMed ID: 27301360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Spontaneous ovulation in in vitro fertilization-embryo transfer cycles using gonadotropin-releasing hormone antagonist: a large-sample retrospective study].
    Luo L; Chen MH; Jia MX; Wang Q; Zhou CQ
    Zhonghua Fu Chan Ke Za Zhi; 2016 May; 51(5):352-6. PubMed ID: 27256442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.